RANCHO CORDOVA, Calif.,
May 28, 2020 /PRNewswire/
-- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market
leader in automated cell processing tools and services in the cell
and gene therapy field, today announced a change in location of its
2020 Annual Meeting of Stockholders to be held at 9:00 AM PT, on Thursday,
June 4, 2020. The new location of will be at the Company's
corporate office, located at 2711 Citrus Rd., Rancho Cordova, CA 95742. Due to the public
health impact of the coronavirus (COVID-19) pandemic and to support
the health, well-being, and safety of its stockholders and
employees, the Company will also provide telephone access to the
meeting; instructions for telephone access are provided below.
While the Company plans to hold its 2020 Annual Meeting of
Stockholders in the manner described in the Notice of Annual
Meeting provided to its stockholders on or about April 23, 2020, to minimize the risk to the
Company's stockholders and employees, the Company encourages all
stockholders to access the 2020 Annual Meeting of Stockholders via
telephone, rather than attending the meeting in person. The 2020
Annual Meeting of Stockholders will only cover the necessary
business items, and there will be no stockholder presentation nor a
question and answer session. In light of restrictions and
guidelines on public gatherings issued by the United States Center
for Disease Control and Prevention (CDC), as well as federal,
state, and local government authorities, only Company employees
needed to conduct the business of the meeting will be present, and
no other employees and directors will be attending the meeting in
person.
Please note that stockholders will not be able to vote or revoke
a proxy through telephone access, nor participate actively or ask
questions. Therefore, to ensure that every vote is counted at the
2020 Annual Meeting of Stockholders, the Company encourages its
stockholders to vote as instructed in the Notice of Internet
Availability of Proxy Materials and/or proxy card, via the
internet, by telephone, or by mailing back the proxy card received
from the Company or from a broker, bank, or other provider.
The Company encourages all stockholders to consider safety first
over attending the meeting in person.
To access the call, please dial 1-844-889-4331 (domestic),
1-412-380-7406 (international) or 1-866-605-3852 (Canada). To access a live webcast of the call,
please visit:
https://thermogenesis.com/investors/news-and-events/events-webcasts.
For further questions regarding how to access the 2020 Annual
Meeting of Stockholders, please contact the Company by using the
contact information set forth below.
About ThermoGenesis Holdings, Inc.
ThermoGenesis
Holdings, Inc., develops, commercializes, and markets a range of
automated technologies for CAR-T and other cell-based therapies.
The Company currently markets a full suite of solutions for
automated clinical biobanking, point-of-care applications, and
automated manufacturing process for the emerging CAR-T
immunotherapy market.
In response to the global COVID-19 pandemic, the Company is
marketing a SARS-CoV-2 (COVID-19) IgM/IgG Antibody Fast Detection
Kit in accordance with Section IV.D. of the "Policy for Diagnostic
Tests for Coronavirus Disease – 2019 during the Public Health
Emergency," issued by the U.S. Food and Drug Administration
on March 16, 2020.
For more information about ThermoGenesis, please visit:
www.ThermoGenesis.com.
For more information about the Company's Rapid COVID-19 Test,
please visit: www.thermogenesis.com/covid-19-test-kit/ or click
here to view the listing on the FDA website
Company
Contact:
Wendy Samford
916-858-5191
ir@ThermoGenesis.com
Investor Contact:
Paula Schwartz, Rx
Communications
917-322-2216
pschwartz@rxir.com
View original
content:http://www.prnewswire.com/news-releases/thermogenesis-holdings-announces-change-in-location-of-2020-annual-meeting-of-stockholders-301067278.html
SOURCE ThermoGenesis Holdings, Inc.